Following our recent finding that blood levels of LEF1-AS1 predict COVID-19 disease severity and in-hospital mortality [13,14], we hereby investigated the ability of LEF1-AS1 to predict persistent symptoms after COVID-19. Here, LEF1 is linked to COVID-19.